Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin in Male UTIs With ESBL-producing Enterobacteriaceae
NCT03868969Phase 2Unknown
- Sponsor
- CHU de Besançon
- Start
- Apr 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fosfomycin in urinary tract infection (UTI), sponsored by CHU de Besançon. Primary endpoint: Number of patients with no signs of urinary tract infection at 28 days. Status: unknown.
02
Drugs
fosfomycin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03868969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03868969.